Dr. Metersky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
263 Farmington Ave
Farmington, CT 06030Phone+1 860-679-3343Fax+1 860-679-4256
Education & Training
- University of California (San Diego) Medical CenterFellowship, Pulmonary Disease and Critical Care Medicine, 1989 - 1992
- Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
- New York University School of MedicineClass of 1985
Certifications & Licensure
- CA State Medical License 1989 - Present
- CT State Medical License 1992 - 2024
- FL State Medical License 2020 - 2022
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top MD Consumers Checkbook
Clinical Trials
- Scleroderma Lung Disease Start of enrollment: 1999 Aug 01
- Bosentan for Poorly Controlled Asthma Start of enrollment: 2008 Dec 01
Publications & Presentations
PubMed
- 154 citationsEpidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza.Mark L. Metersky, Robert G. Masterton, Hartmut Lode, Thomas M. File, Timothy Babinchak
International Journal of Infectious Diseases. 2012-05-01 - 1610 citationsDiagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases S...Joshua P. Metlay, Grant W. Waterer, Ann C. Long, Antonio Anzueto, Jan Brozek
American Journal of Respiratory and Critical Care Medicine. 2019-10-01 - 364 citationsManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and th...Andre C Kalil, Mark L Metersky, Michael Klompas, John Muscedere, Daniel A Sweeney
Clinical Infectious Diseases. 2016-09-01
Journal Articles
- Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in BronchiectasisMark L Metersky, Charles L Daley, The New England Journal of Medicine
- Association Between Medicare Expenditures and Adverse Events for Patients with Acute Myocardial Infarction, Heart Failure, or Pneumonia in the United StatesMark L Metersky, Harlan M Krumholz, JAMA Network Open
- Case Report Bordetella Bronchiseptica in Non-Cystic Fibrosis BronchiectasisVanessa L Yap, Elham Karamooz, Mark L Metersky, Alan F Barker, ScienceDirect
Authored Content
- Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
- Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013November 2016
Press Mentions
- COVID-19 Burden in Hospitals Affects Risk for in-Hospital Adverse EventsNovember 8th, 2024
- U.S. Hospitals Are Getting Safer for Patients, Study FindsJuly 20th, 2022
- COPD as a Lung Stem Cell Disease: Single Cell Cloning Tells the Story of Abnormal CellsApril 15th, 2020
- Join now to see all
Grant Support
- Obstacles To Usage Of The Pneumoccocal VaccineNational Center For Research Resources1998–1999
- Compliance With Tuberculosis Prophylaxis After Release For Correctional FacilityNational Center For Research Resources1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: